Descrizione:

AIDS-Related Non-Hodgkin's Lymphoma Baseline Lymphoma Disease Activity and Assessment (LAA) Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma NCT00310128 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=11409201-BB50-09A2-E044-0003BA3F9857

collegamento:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=11409201-BB50-09A2-E044-0003BA3F9857
Keywords:
  1. 26/08/12 26/08/12 -
  2. 03/02/15 03/02/15 - Martin Dugas
  3. 13/04/21 13/04/21 - Dr. rer. medic Philipp Neuhaus
  4. 20/09/21 20/09/21 -
Caricato su:

20 settembre 2021

DOI:
Per favore, per richiedere un accesso.
Licenza :
Creative Commons BY-NC 3.0 Legacy
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Baseline Lymphoma Disease Activity and Assessment

No Instruction available.

  1. StudyEvent: Baseline Lymphoma Disease Activity and Assessment (LAA)
    1. No Instruction available.
Lymphoma disease activity
Modified Ann Arbor Stage
Recurring, drenching night sweats during the previous month
Unexplained, persistent fever >38 degrees C (or >100 degrees F) in the previous month
Unexplained weight loss above 10% of body weight in the previous 6 months
Hematopoietic Diagnosis
If diffuse large B-cell lymphoma, specify morphologic type
If Burkitt lymphoma/leukemia, specify morphologic type
Method of Evaluation
Is the participant >60 years of age
Does the participant have Stage III or IV disease
Is the serum LDH elevated
Is the ECOG Performance Status 2, 3, or 4
Does the participant have two or more extranodal disease sites
IPI Risk Category

Similar models

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial